CS logo
small CS logo
Comite Mexicano Para la Prevencion de Osteoporosis AC

Mexico, Mexico

About Comite Mexicano Para la Prevencion de Osteoporosis AC


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Comite Mexicano Para la Prevencion de Osteoporosis AC


During the past decade, Comite Mexicano Para la Prevencion de Osteoporosis AC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Comite Mexicano Para la Prevencion de Osteoporosis AC" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Comite Mexicano Para la Prevencion de Osteoporosis AC


According to Clinical.Site data, the most researched conditions in "Comite Mexicano Para la Prevencion de Osteoporosis AC" are "Rheumatoid Arthritis" (3 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Comite Mexicano Para la Prevencion de Osteoporosis AC" in a lesser frequency.

Clinical Trials Intervention Types at Comite Mexicano Para la Prevencion de Osteoporosis AC


Most popular intervention types in "Comite Mexicano Para la Prevencion de Osteoporosis AC" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab 40mg q2w" (1 trials), "Concomitant treatment" (1 trials), "Etanercept" (1 trials), "Linagliptin" (1 trials) and "Olokizumab 64 mg SC q2w" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Comite Mexicano Para la Prevencion de Osteoporosis AC


The vast majority of trials in "Comite Mexicano Para la Prevencion de Osteoporosis AC" are 4 trials for "All" genders.

Clinical Trials Status at Comite Mexicano Para la Prevencion de Osteoporosis AC


Currently, there are NaN active trials in "Comite Mexicano Para la Prevencion de Osteoporosis AC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Comite Mexicano Para la Prevencion de Osteoporosis AC, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Comite Mexicano Para la Prevencion de Osteoporosis AC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".